Lars Hagberg Selected Research

Central Nervous System Infections (Central Nervous System Infection)

1/2022	Cerebrospinal Fluid Viral Load Across the Spectrum of Untreated Human Immunodeficiency Virus Type 1 (HIV-1) Infection: A Cross-Sectional Multicenter Study.
12/2021	CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series.
1/2018	Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
12/2013	Approach to cerebrospinal fluid (CSF) biomarker discovery and evaluation in HIV infection.
7/2013	Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections.
2/2013	Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections.
12/2012	Cerebrospinal fluid viral breakthrough in two HIV-infected subjects on darunavir/ritonavir monotherapy.
9/2011	Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden.
12/2010	Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy.
6/2010	Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lars Hagberg Research Topics

Disease

22	Infections 01/2022 - 11/2002
15	HIV Infections (HIV Infection) 07/2022 - 08/2005
10	Central Nervous System Infections (Central Nervous System Infection) 01/2022 - 06/2010
10	Inflammation (Inflammations) 12/2021 - 12/2009
6	AIDS Dementia Complex 06/2010 - 05/2004
5	Dementia (Dementias) 01/2022 - 01/2014
5	Lyme Neuroborreliosis 09/2011 - 01/2005
4	Neurologic Manifestations (Neurological Manifestations) 01/2022 - 05/2004
4	Encephalitis (Encephalitis, Rasmussen) 01/2020 - 12/2004
4	Alzheimer Disease (Alzheimer's Disease) 01/2014 - 12/2009
4	Neuroinflammatory Diseases 01/2014 - 06/2010
4	Brain Injuries (Brain Injury) 01/2014 - 03/2007
4	Central Nervous System Diseases (CNS Diseases) 12/2013 - 12/2004
3	Opportunistic Infections (Opportunistic Infection) 07/2022 - 12/2009
3	Acquired Immunodeficiency Syndrome (AIDS) 06/2013 - 03/2007
3	Leukocytosis (Pleocytosis) 09/2011 - 07/2004
2	Disease Progression 01/2022 - 06/2013
2	COVID-19 01/2022 - 12/2021
2	Fatigue 01/2021 - 08/2017
2	Communicable Diseases (Infectious Diseases) 02/2018 - 01/2005
2	Persistent Infection 01/2018 - 09/2011
2	Erythema 08/2011 - 05/2006
2	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2007 - 03/2007
1	Pain (Aches) 01/2021
1	Malnutrition (Nutritional Deficiencies) 01/2018
1	Endometritis 01/2018
1	Wound Infection (Wound Infections) 01/2018
1	Exocrine Pancreatic Insufficiency 01/2018
1	Osteomyelitis 12/2017
1	Body Weight (Weight, Body) 12/2017
1	Neoplasms (Cancer) 12/2017
1	Wounds and Injuries (Trauma) 12/2017
1	Ischemia 12/2017
1	Breast Neoplasms (Breast Cancer) 08/2017
1	Cognitive Dysfunction 04/2016
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2014
1	Heart Arrest (Cardiac Arrest) 02/2014
1	Out-of-Hospital Cardiac Arrest 02/2014
1	Hematologic Neoplasms (Hematological Malignancy) 01/2014
1	Fever (Fevers) 01/2014
1	Neuromuscular Diseases (Neuromuscular Disease) 09/2011
1	Bell Palsy (Bell's Palsy) 08/2011
1	Viremia 12/2010
1	Multiple Sclerosis 06/2010
1	Cryptococcal Meningitis 06/2010

Drug/Important Bio-Agent (IBA)

22	Biomarkers (Surrogate Marker)IBA 07/2022 - 09/2006
13	RNA (Ribonucleic Acid)IBA 07/2022 - 08/2005
12	NeopterinIBA 12/2021 - 07/2004
11	Proteins (Proteins, Gene)FDA Link 07/2022 - 11/2005
6	Amyloid (Amyloid Fibrils)IBA 12/2015 - 12/2009
4	AlbuminsIBA 12/2021 - 08/2011
4	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 01/2019 - 06/2007
4	Serum AlbuminIBA 01/2017 - 09/2011
4	Amyloid beta-PeptidesIBA 06/2013 - 12/2009
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2018 - 10/2010
3	Doxycycline (Periostat)FDA LinkGeneric 09/2011 - 01/2003
2	Indicators and Reagents (Reagents)IBA 01/2019 - 08/2007
2	AntibodiesIBA 01/2018 - 08/2011
2	TitaniumIBA 12/2017 - 10/2010
2	Neurofilament ProteinsIBA 07/2013 - 08/2007
2	Interferon-gamma (Interferon, gamma)IBA 06/2013 - 11/2005
2	Ritonavir (Norvir)FDA Link 12/2012 - 09/2006
2	ChemokinesIBA 09/2011 - 11/2005
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 12/2004 - 05/2004
1	Viral AntigensIBA 01/2022
1	Viral RNAIBA 01/2022
1	Immunoglobulin G (IgG)IBA 12/2021
1	ametantrone (HAQ)IBA 01/2021
1	HIV AntibodiesIBA 01/2018
1	Anti-Infective Agents (Microbicides)IBA 11/2017
1	LipopolysaccharidesIBA 04/2016
1	Lipopolysaccharide ReceptorsIBA 04/2016
1	HomocysteineIBA 01/2016
1	Peptides (Polypeptides)IBA 01/2014
1	neurofilament protein LIBA 01/2014
1	ProteomeIBA 12/2013
1	Biological ProductsIBA 12/2013
1	DNA (Deoxyribonucleic Acid)IBA 07/2013
1	Glial Fibrillary Acidic ProteinIBA 07/2013
1	Protons (Proton)IBA 06/2013
1	Darunavir (Prezista)FDA Link 12/2012
1	Dystroglycans (Dystroglycan)IBA 09/2011
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2011
1	CoagulaseIBA 10/2010
1	MetalsIBA 10/2010

Therapy/Procedure

7	Therapeutics 02/2018 - 11/2002
2	Surgical Amputation (Amputations) 12/2017 - 11/2017
2	Drug Therapy (Chemotherapy) 08/2017 - 01/2014
2	Aftercare (After-Treatment) 08/2017 - 06/2010
2	Highly Active Antiretroviral Therapy (HAART) 06/2010 - 09/2006
1	Length of Stay 02/2018
1	Art Therapy 01/2018
1	Cesarean Section (Caesarean Section) 01/2018
1	Antibiotic Prophylaxis 01/2018
1	Operative Surgical Procedures 12/2017
1	Prostheses and Implants (Prosthesis) 12/2017
1	Conservative Treatment 12/2017
1	Adjuvant Chemotherapy 08/2017
1	Cranial Irradiation 07/2014
1	Bone-Anchored Prosthesis 10/2010